CHINA has agreed to stop its pharmaceutical manufacturers from copying medicines patented in Austria, Finland and Sweden, extending 'administrative protection' enjoyed by the rest of the European Union to these countries.

Beijing has been refusing to grant these rights - which are a form of patent protection - because when it agreed to stop its citizens copying European Union patented pharmaceuticals, neither Austria, Sweden nor Finland were EU members.

As a result, manufacturers from these three countries have suffered an ...

Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.